A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...] …
Category: Pharma Industry
Pharmaceutical giant AbbVie recently urged a federal judge to rule on its suit against Louisiana’s 340B contract pharmacy law without [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers issued a record 41 refunds to 340B covered entities in 2023. And Merck is the first to announce it [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Just days prior to implementing its first contract pharmacy restrictions, Japanese pharmaceutical giant Takeda yesterday announced it will increase the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Influential state senators in Kentucky, Virginia, and Florida have introduced bills recently that would prohibit drug manufacturer restrictions on 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Novo Nordisk’s deal with Arkansas restoring 340B discounts in the contract pharmacy setting until a coming appeals court ruling, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies [...] …